BackgroundCheck.run
Search For

Subba R Katamreddy, 649309 Teton Pines Way, Raleigh, NC 27617

Known as:
Subba Reddy Katamreddy Subba V Katamreddy Vijaya L Katamreddy Subba Y

Subba Katamreddy Phones & Addresses

9309 Teton Pines Way, Raleigh, NC 27617    919-7681537    919-8060736   

2133 Winter Walk Cir, Morrisville, NC 27560    919-4630756   

Atlanta, GA   

Research Triangle Park, NC   

9309 Teton Pines Way, Raleigh, NC 27617    919-8060736   

Work

Position: Professional/Technical

Education

Degree: High school graduate or higher

Emails

l***[email protected]
Get Report
Control this profile

Mentions for Subba R Katamreddy

Subba Katamreddy resumes & CV records

Resumes

Subba Katamreddy Photo 9

President

Location:
Raleigh, NC
Industry:
Pharmaceuticals
Work:
Vijaya Pharmaceuticals since Jan 2009
Scientific Advisor GlaxoSmithKline Jul 2001 - Aug 2008
Principal Scientist & Research Investigator Emory University Nov 1998 - Jun 2001
Post-Docotoral Fellow
Education:
Pondicherry University 1988 - 1994
Ph.D, Organic ChemistryThesis title: Studies in stereochemistry: Stereoselectivity in cyclic beta-ketoester alkylations and cyclic enone reductions.
Skills:
Synthetic Organic Chemistry, Medicinal Chemistry, Carbohydrate Chemistry, Asymmetric Synthesis, Innovative Problem Solver, Drug Discovery, Lead Generation and Lead Optimization, Metabolic Diseases, Drug Design, Pharmaceuticals
Subba Katamreddy Photo 10

Research Investigator

Location:
Raleigh, NC
Industry:
Research
Work:
Gsk
Research Investigator
Subba Katamreddy Photo 11

President

Location:
Raleigh, NC
Work:
Spv Therapeutics
President
Subba Katamreddy Photo 12

Scientific Advisor At Vijaya Pharmaceuticals

Location:
Raleigh-Durham, North Carolina Area
Industry:
Pharmaceuticals

Publications & IP owners

Us Patents

Cycloalkylidene Compounds As Modulators Of Estrogen Receptor

US Patent:
7569601, Aug 4, 2009
Filed:
May 14, 2007
Appl. No.:
11/748096
Inventors:
Jing Fang - Durham NC, US
Dennis Heyer - Durham NC, US
Aaron Bayne Miller - Durham NC, US
Frank Navas, III - Durham NC, US
William J. Zuercher - Durham NC, US
Subba Reddy Katamreddy - Durham NC, US
Assignee:
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
A61K 31/351
C07D 315/00
US Classification:
514459, 549426
Abstract:
The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation.

Naphthalene Compounds As Selective Estrogen Receptor Modulators

US Patent:
7649093, Jan 19, 2010
Filed:
Jun 21, 2005
Appl. No.:
11/570838
Inventors:
Dennis Heyer - Durham NC, US
Jing Fang - Durham NC, US
Frank Navas, III - Durham NC, US
Subba Reddy Katamreddy - Durham NC, US
Jennifer Poole Peckham - Durham NC, US
Philip Stewart Turnbull - Durham NC, US
Aaron Bayne Miller - Durham NC, US
Adwoa Akwabi-Ameyaw - Durham NC, US
Assignee:
Glaxo Smith Kline LLC - Wilmington DE
International Classification:
C07D 471/00
C07D 295/00
A61K 31/445
US Classification:
546 86, 514319, 544386
Abstract:
The present invention relates to cycloalkylidene compounds with a variety of therapeutic uses, more particularly novel naphthalene compounds that are particularly useful for selective estrogen receptor modulation.

Cycloalkylidene Compounds As Selective Estrogen Receptor Modulators

US Patent:
7723393, May 25, 2010
Filed:
May 24, 2006
Appl. No.:
11/915436
Inventors:
Jing Fang - Durham NC, US
Dennis Heyer - Durham NC, US
Subba Reddy Katamreddy - Durham NC, US
Kenneth William Batchelor - Durham NC, US
Richard Dana Caldwell - Durham NC, US
Assignee:
GlaxoSmithKline LLC - Philadelphia PA
International Classification:
A01N 35/00
C07D 309/00
US Classification:
514683, 514754, 514766, 562468, 549356
Abstract:
The present invention relates to compounds of formula (I) with a variety of therapeutic uses, more particularly the substituted cyclic alkylidene compounds are useful for selective estrogen receptor modulation.

Cycloalkylidene Compounds As Modulators Of Estrogen Receptor

US Patent:
7799828, Sep 21, 2010
Filed:
Jun 8, 2009
Appl. No.:
12/480097
Inventors:
Jing Fang - Durham NC, US
Dennis Heyer - Durham NC, US
Aaron Bayne Miller - Durham NC, US
Frank Navas, III - Durham NC, US
William J. Zuercher - Durham NC, US
Subba Reddy Katamreddy - Durham NC, US
Assignee:
GlaxoSmithKline LLC - Philadelphia PA
International Classification:
A61K 31/351
US Classification:
514459
Abstract:
The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation.

Bicyclic Compounds And Use As Antidiabetics

US Patent:
8101634, Jan 24, 2012
Filed:
Dec 5, 2007
Appl. No.:
12/517620
Inventors:
Jing Fang - Durham NC, US
Jun Tang - Durham NC, US
Andrew J Carpenter - Durham NC, US
Gregory Peckham - Durham NC, US
Christopher R Conlee - Durham NC, US
Kien S Du - Durham NC, US
Subba Reddy Katamreddy - Durham NC, US
Assignee:
GlaxoSmithKline LLC - Philadelphia PA
International Classification:
A61K 31/424
A61K 31/445
C07D 401/14
C07D 413/14
US Classification:
514315, 546184
Abstract:
The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.

Chemical Compounds

US Patent:
8222261, Jul 17, 2012
Filed:
Jan 13, 2009
Appl. No.:
12/373524
Inventors:
Subba R Katamreddy - Durham NC, US
Richard Dama Caldwell - Durham NC, US
Dennis Heyer - Durham NC, US
Vincente Samano - Durham NC, US
James Benjamin Thompson - Durham NC, US
Andrew J Carpenter - Durham NC, US
Christopher R Conlee - Durham NC, US
Eric Eugene Boros - Durham NC, US
Brian D Thompson - Durham NC, US
Assignee:
GlaxoSmithKline, LLC - Philadelphia PA
International Classification:
A61K 31/519
US Classification:
5142651
Abstract:
The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly Type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.

Novel Compounds

US Patent:
2007011, May 17, 2007
Filed:
Oct 4, 2004
Appl. No.:
10/575038
Inventors:
John Eaddy - Durham NC, US
Dennis Heyer - Durham NC, US
Amarjit Randhawa - Durham NC, US
Vicente Sanano - Durham NC, US
John Ray - Durham NC, US
Subba Katamreddy - Durham NC, US
Michael Martin - Durham NC, US
Michael McClure - Durham NC, US
International Classification:
A61K 31/66
US Classification:
514124000, 514568000
Abstract:
Compounds of formula (I): with a variety of therapeutic uses, more particularly novel prodrugs that are particularly useful for delivering a parent compound for selective estrogen receptor modulation.

Chemical Compounds

US Patent:
2008023, Sep 25, 2008
Filed:
Nov 22, 2006
Appl. No.:
12/094189
Inventors:
Subba Reddy Katamreddy - Durham NC, US
International Classification:
A61K 31/42
C07C 59/52
C07C 235/34
C07D 261/08
C07D 307/42
C07D 231/12
A61K 31/34
A61K 38/27
A61K 31/568
A61P 3/00
A61P 1/00
A61P 35/00
A61P 19/00
A61K 31/566
A61K 38/29
A61K 38/25
A61K 31/415
C07C 43/23
A61K 31/192
A61K 31/165
A61K 31/085
US Classification:
514 12, 562468, 564171, 548247, 549502, 5483731, 568640, 514570, 514622, 514720, 514378, 514406, 514461, 514171
Abstract:
Triphenylethylene compounds of formula (I) are provided. The compounds are particularly useful for selective estrogen receptor modulation.

Possible Relatives

Subba M Rao 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.